Article Details
Retrieved on: 2024-10-10 20:15:57
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Sutro Biopharma's use of a cell-free platform to develop next-generation antibody-drug conjugates (ADCs) in biotechnology and immunology, particularly focusing on innovations like dual-payload ADCs and immunostimulatory ADCs.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here